SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001161697-18-000026
Filing Date
2018-01-04
Accepted
2018-01-04 16:48:59
Documents
1
Period of Report
2018-01-02

Document Format Files

Seq Description Document Type Size
1 FORM 4 FOR 01-02-2018 form4.html 4  
1 FORM 4 FOR 01-02-2018 form4.xml 4 5836
  Complete submission text file 0001161697-18-000026.txt   7466
Mailing Address 355 ALHAMBRA CIRCLE SUITE 1500 CORAL GABLES FL 33134
Business Address
DENKHAUS DONALD A (Reporting) CIK: 0001278439 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33057 | Film No.: 18510715

Mailing Address 355 ALHAMBRA CIRCLE SUITE 1250 CORAL GABLES FL 33134
Business Address 355 ALHAMBRA CIRCLE SUITE 1250 CORAL GABLES FL 33134 (305) 529-2522
CATALYST PHARMACEUTICALS, INC. (Issuer) CIK: 0001369568 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations